Germline Mutations of the Paired–Like Homeobox 2B (PHOX2B) Gene in Neuroblastoma  by Trochet, Delphine et al.
Am. J. Hum. Genet. 74:761–764, 2004
761
Report
Germline Mutations of the Paired–Like Homeobox 2B (PHOX2B) Gene
in Neuroblastoma
Delphine Trochet,1 Franck Bourdeaut,2 Isabelle Janoueix-Lerosey,2 Anne Deville,3
Loı¨c de Pontual,1 Gudrun Schleiermacher,2 Carole Coze,4 Nicole Philip,5 Thierry Fre´bourg,6
Arnold Munnich,1 Stanislas Lyonnet,1 Olivier Delattre,2 and Jeanne Amiel1
1Unite´ de Recherches sur les Handicaps Ge´ne´tiques de l’Enfant, INSERM U-393, and De´partement de Ge´ne´tique, Hoˆpital Necker-Enfants
Malades, and 2Unite´ de Pathologie Mole´culaire des Cancers, INSERM U-509, Institut Curie, Paris; 3Centre Me´dical Infantile, Fondation
Lenval, Nice; 4Service d’Oncologie Pe´diatrique and 5Service de Ge´ne´tique, Hoˆpital d’Enfants La Timone, Marseille; and 6Service
de Ge´ne´tique, Hoˆpital Charles Nicolle, Rouen
Neuroblastoma (NB) is a frequent pediatric tumor for which recurrent somatic rearrangements are known.Germline
mutations of predisposing gene(s) are suspected on the basis of rare familial cases and the association of NB with
other genetically determined congenital malformations of neural crest–derived cells—namely, Hirschsprung disease
(HSCR) and/or congenital central hypoventilation syndrome (CCHS). We recently identiﬁed the paired–like homeo-
box 2B (PHOX2B) gene as the major disease-causing gene in isolated and syndromic CCHS, which prompted us
to regard it as a candidate gene in NB. Here, we report on germline mutations of PHOX2B in both a familial case
of NB and a patient with the HSCR-NB association. PHOX2B, therefore, stands as the ﬁrst gene for which germline
mutations predispose to NB.
Neuroblastoma (NB [MIM 256700]) is a tumor of the
sympathetic nervous system that accounts for ∼10% of
all cancers in childhood.Although nopredisposinggene(s)
have been identiﬁed thus far, several lines of evidence
support the involvement of genetic factors in NB, namely,
rare familial cases with vertical transmission and multi-
focality (Chatten and Voorhess 1967; Clausen et al. 1989;
Maris et al. 1997, 2002) and the association of NB with
other genetically determined congenital malformations of
neural-crest origin, such as Hirschsprung disease (HSCR
[MIM 142623]) and/or congenital central hypoventila-
tion syndrome (CCHS, also known as “Ondine’s curse”
[MIM 209880]) (Rohrer et al. 2002). In particular, pa-
tients with CCHS have a high predisposing risk of de-
veloping a tumor of the sympathetic nervous system (i.e.,
5%–10% occurrence of NB, ganglioneuroblastoma, and
ganglioneuroma—versus 1/10,000 in the general popu-
lation) (Rohrer et al. 2002). We recently identiﬁed the
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paired–like homeobox 2B (PHOX2B [MIM 603851])
gene as the major disease-causing gene of CCHS, with an
autosomal dominant mode of inheritance and de novo
mutation in the ﬁrst generation (Amiel et al. 2003).More-
over, we showed that isolated CCHS and CCHS associ-
ated with HSCR (Haddad syndrome), whatever the pres-
ence or absence of NB, are allelic conditions.We therefore
regarded PHOX2B as a candidate gene for both familial
and syndromic NB. Here, we report on heterozygousmis-
sensemutations located in the homeodomain of PHOX2B
in both a familial case of NB (mutation R100L) and an
isolated case of NB associated with HSCR (mutation
R141G). These data suggest that germline mutation at
the PHOX2B locus predispose to hereditary NB.
Patient 1, a male, was the ﬁrst child born to noncon-
sanguineous parents. A multifocal abdominal ganglio-
neuroma was surgically removed from the patient at age
10 years. His younger brother presented with an abdomi-
nal NB, at age 6 years, which was surgically removed,
and experienced local recurrences 18 mo and 30 mo
later. No MYCN ampliﬁcation was detected. His sister
is 10 years old and healthy. The father had a ganglioneu-
roma of the adrenal medulla, which was surgically re-
moved at age 44 years (ﬁg. 1A).
Patient 2, a male, was born to nonconsanguineous
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Figure 1 PHOX2B mutations in familial and syndromic neuroblastoma. A, Pedigree of patients 1 and 2. B, Genomic organization of the
PHOX2B protein. The homeobox domain and the 9- and 20-residue polyalanine tracts are indicated by blue and green boxes, respectively. C,
DNA sequence electrophoregrams of exon 2 of the PHOX2B gene, showing missense heterozygous mutations in the homeobox. Wild-type
(WT) (top) and mutant (bottom) sequences are indicated.
parents after an uneventful pregnancy. He received the
diagnosis of HSCR in the neonatal period and was
treated surgically, with a good result. Multifocal tumors,
both thoracic and abdominal, were diagnosed at age 9
mo and were surgically removed. The histological ex-
amination conﬁrmed the diagnosis of multifocal NB. No
MYCN ampliﬁcation could be detected. A simple survey,
with a 10-year follow-up, showed no recurrence (ﬁg. 1A).
Patient 3, a male, presented with an NB at age 3 years,
whereas his maternal half-sister presented with a ganglio-
neuroblastoma at age 1 year. The mother is asymptom-
atic, now aged 39 years (pedigree not shown).
Blood samples were obtained, after receiving informed
consent from patients, for DNA analyses, and DNA was
extracted from peripheral leukocytes following standard
protocols. We screened the entire coding sequence of the
PHOX2B gene by direct DNA sequencing. Primers used
for PCR ampliﬁcation of PHOX2B are as follows: exon
1 (F 5′-GCCACCTTCTCCATATCC-3′; R 5′-GAAAGG-
CGGCTTCCTCCG-3′), exon 2 (F 5′-GCTCCACGGC-
CGGCGAGCTG-3′; R 5′-CTCCCCGGACCAGTGCG-
GCG-3′), exon 3A (F 5′-GGCCACCCTAACCGGTGC-3′;
R 5′-GGCCACCCTAACCGGTGC-3′), and exon 3B (F
5′-CCAGCTGCGGGGCGAATG-3′; R 5′-CTGGCTCG-
CCCGCTGTC-3′). The PCR reaction mixture (25 ml)
contained 100 ng of leukocyte DNA, 20 pmol of each
primer, 0.1 mM dNTP, 0.07 ml of 33PdCTP, and 1 U Taq
DNA polymerase (Taq [Invitrogen] or Taq Expand
[Roche]). DNA sequencing was performed by the ﬂuoro-
metric method on both strands (Big DyeTerminator Cy-
cle Sequencing kit [Applied Biosystems]).
In patient 1, we identiﬁed a heterozygous GrT trans-
version at nucleotide 299 in exon 2 of the PHOX2B
gene, presumably changing an arginine into a leucine in
the homeodomain of the protein (R100L) (ﬁg. 1C). The
mutation was inherited from the father; it segregated to
his younger affected son but not to his healthy daughter
(ﬁg. 1A). A tumoral DNA sample was available for pa-
tient 1, and PCR ampliﬁcation showed no loss of hetero-
zygosity (LOH) at the PHOX2B locus (data not shown).
In patient 2, we identiﬁed a heterozygous CrG trans-
version at nucleotide 421 in exon 2 of the PHOX2B
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gene, changing an arginine into a glycine in the homeo-
domain (R141G) (ﬁg. 1C). The mutation was inherited
from the mother. It is unfortunate that no tumoral sam-
ple for patient 2 was available for study.
Both nucleotidic changes were absent from a panel of
220 control chromosomes and involved extremely con-
served amino acids within the homeodomain family pro-
teins among different species. No nucleotide change was
detected in the PHOX2B coding sequence for patient 3.
The human PHOX2B gene maps to chromosome
4p12 and encodes a highly conserved 314–amino acid
homeobox transcription factor (ﬁg. 1B) (Yokoyama et
al. 1999). The knockout of the mouse ortholog dem-
onstrated that Phox2b is the master gene for both central
and peripheral autonomic nervous-system development,
since all neurons of the autonomic circuit are absent in
Phox2b/ mice (Pattyn et al. 2000; Brunet and Pattyn
2002). Moreover, Phox2b has been shown to regulate
neuronal cell cycle (Dubreuil et al. 2000). Mutation and
expression studies in humans showed that PHOX2B is
involved in a wide spectrum of autonomic nervous sys-
tem disorders, ranging from dysgenetic malformations
(CCHS and HSCR) to tumor predisposition (NB) (Amiel
et al. 2003). However, PHOX2B gene mutations iden-
tiﬁed thus far in patients with isolated or syndromic
CCHS have been either in-frame–polyalanine expan-
sions or frameshift mutations, in contrast with the mis-
sense mutations identiﬁed in patients showing tumor
predisposition without the CCHS phenotype. In the lat-
ter case, either loss-of-function or dominant negative ef-
fects could be speculated. Indeed, on the one hand, the
fact that both missense mutations of the homeodomain
and frameshift mutations predispose to NB (with or
without CCHS) would favor haploinsufﬁciency. On the
other hand, since the R100 residue of the homeodomain
has been shown to contact DNA of target genes (Ba-
nerjee-Basu et al. 2003), its substitution could result in
loss of DNA binding, whereas its ability to dimerizewith
the wild-type PHOX2B or other proteins could be re-
tained, resulting in a dominant negative effect.
Several recurrent somatic rearrangements have been
described in NB, namely, ampliﬁcation of the MYCN
proto-oncogene, duplication of the 17q13-qter chromo-
some bands, and deletions of the 1p36, 11q23, and
14q23-qter chromosomal regions (Maris and Matthay
1999). Ampliﬁcation of MYCN and the 1p36 deletion
are both associated with a poorer outcome (Weinstein
et al. 2003). Here we show that missensemutations lying
in the homeodomain of the protein predispose to NB.
No LOH could be found in the tumoral sample of pa-
tient 1. Although this result argues against the two-hit
model proposed for NB (Knudson and Meadows 1976),
no conclusion can be drawn from this single case. In
particular, LOH may have been underestimated owing
to a sample contamination by nontumoral cells.
The R141G mutation identiﬁed in patient 2 is inher-
ited from the healthy mother (ﬁg. 1A and 1C). Several
hypotheses could be proposed to explain this observa-
tion: (i) the tumor may develop in adulthood, as in family
1 (the father was diagnosed with ganglioneuroma in his
40s), (ii) spontaneous tumor regression is a well-known
phenomenon for the sympathetic nervous system (Beck-
with and Perrin 1963), and (iii) incomplete penetrance,
higher for tumor predisposition than for HSCR, was al-
ready suspected in pedigrees with NB (Maris et al. 1997,
2002) like that described in families with retinoblastoma
or Wilms tumor. It is interesting that heterozygous germ-
line gain-of-function mutations of the RET proto-on-
cogene predispose to both multiple-endocrine neoplasia
type 2A, with a high penetrance, and HSCR, with a
lower one (Mulligan et al. 1994). The underlying mech-
anism accounting for this dual effect (congenital mal-
formation and tumor predisposition) has been charac-
terized in vitro; missense mutations at codons C609,
C618, and C620 are responsible for both an altered
translocation of the RET tyrosine kinase receptor to the
plasma membrane, leading to haploinsufﬁciency during
enteric–nervous system development, whereas consti-
tutive activation of the RET molecules that reached the
cell surface results in cellular transformation (Chappuis-
Flament et al. 1998; Hansford and Mulligan 2000).
Recent results suggest that hereditary NB is heteroge-
neous. Indeed, linkage analysis of seven families with two
or more ﬁrst-degree relatives demonstrated cosegregation
of NB with 16p markers (Maris et al. 2002). Another
report has recently suggested cosegregationwith 4pmark-
ers in a large pedigree with NB (Perri et al. 2002). It is
interesting that this last study also demonstrated loss of
heterozygosity at 4p loci, suggesting a two-hit mechanism
for tumorigenesis. It will be of interest to test whether
PHOX2B, the gene of which is mapping to 4p12, could
be the susceptibility gene involved in the family reported
by Perri et al. (2002), although the linked region is telo-
meric to the PHOX2B locus. Moreover, genes known to
be involved in the Mash1-Phox-Ret pathway (required in
the development of sympathetic and enteric nervous sys-
tems) (Pattyn et al. 1999) are not located in those can-
didate intervals. Finally, the RET locus, at 10q11.2, has
already been excluded by linkage analysis in familial NB
(Maris et al. 1997). Further studies should enable us to
determine whether dominant negative effect or haploin-
sufﬁciency account for the role of PHOX2B in the de-
velopment of NB.
A high level of expression of most 3–amino acid loop
extension (TALE)–family-member genes is found in NB
cell lines (Geerts et al. 2003). TALE genes are homeobox
genes known to play a role in the development of the
nervous system and implicated in tumorigenesis. TALE
proteins bind other homeobox proteins via their TALE
insertion in the homeodomain, whereas heterodimeri-
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zation enhances the afﬁnity and speciﬁcity of DNA bind-
ing. The question of whether PHOX2B is a partner of
one (or several) of this gene-family members remains
open, a hypothesis that could well establish a link be-
tween predisposing PHOX2B mutation and other mo-
lecular events observed in NB.
Thus, PHOX2B is the ﬁrst gene predisposing to NB
for which germline mutations have been identiﬁed. Fur-
ther studies are needed to investigate its putative role in
sporadic NB.
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